News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
340,318 Results
Type
Article (27530)
Company Profile (119)
Press Release (312660)
Multimedia
Podcasts (40)
Webinars (11)
Section
Business (88611)
Career Advice (1169)
Deals (15369)
Drug Delivery (47)
Drug Development (51205)
Employer Resources (84)
FDA (7734)
Job Trends (7636)
News (165035)
Policy (17370)
Tag
Academia (1441)
Academic (1)
Accelerated approval (9)
Adcomms (18)
Allergies (41)
Alliances (26456)
ALS (82)
Alzheimer's disease (811)
Antibody-drug conjugate (ADC) (239)
Approvals (7793)
Artificial intelligence (268)
Autoimmune disease (59)
Automation (10)
Bankruptcy (137)
Best Places to Work (6628)
BIOSECURE Act (5)
Biosimilars (94)
Biotechnology (93)
Bladder cancer (136)
Brain cancer (49)
Breast cancer (516)
Cancer (4012)
Cardiovascular disease (151)
Career advice (998)
Career pathing (20)
CAR-T (198)
CDC (20)
Cell therapy (439)
Cervical cancer (33)
Clinical research (43033)
Collaboration (864)
Company closure (4)
Compensation (315)
Complete response letters (39)
COVID-19 (1149)
CRISPR (32)
C-suite (263)
Cystic fibrosis (49)
Data (3043)
Decentralized trials (2)
Denatured (5)
Depression (45)
Diabetes (203)
Diagnostics (4402)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (25)
Drug discovery (117)
Drug pricing (68)
Drug shortages (15)
Duchenne muscular dystrophy (93)
Earnings (34124)
Editorial (18)
Employer branding (13)
Employer resources (76)
Events (53417)
Executive appointments (446)
FDA (9138)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (676)
Gene editing (62)
Generative AI (14)
Gene therapy (205)
GLP-1 (431)
Government (2870)
Grass and pollen (1)
Guidances (206)
Healthcare (10668)
HIV (29)
Huntington's disease (15)
IgA nephropathy (21)
Immunology and inflammation (146)
Immuno-oncology (17)
Indications (42)
Infectious disease (1256)
Inflammatory bowel disease (101)
Inflation Reduction Act (7)
Influenza (46)
Intellectual property (106)
Interviews (183)
IPO (7696)
IRA (20)
Job creations (1328)
Job search strategy (877)
Kidney cancer (16)
Labor market (20)
Layoffs (267)
Leadership (16)
Legal (3938)
Liver cancer (91)
Longevity (7)
Lung cancer (581)
Lymphoma (249)
Machine learning (23)
Management (25)
Manufacturing (280)
MASH (79)
Medical device (4237)
Medtech (4247)
Mergers & acquisitions (8166)
Metabolic disorders (504)
Multiple sclerosis (75)
NASH (7)
Neurodegenerative disease (81)
Neuropsychiatric disorders (23)
Neuroscience (1269)
NextGen: Class of 2025 (3361)
Non-profit (2877)
Now hiring (9)
Obesity (226)
Opinion (158)
Ovarian cancer (139)
Pain (70)
Pancreatic cancer (176)
Parkinson's disease (99)
Partnered (15)
Patents (222)
Patient recruitment (197)
Peanut (16)
People (25192)
Pharmaceutical (23)
Pharmacy benefit managers (17)
Phase I (14708)
Phase II (18828)
Phase III (13783)
Pipeline (1689)
Policy (117)
Postmarket research (1328)
Preclinical (6177)
Press Release (18)
Prostate cancer (204)
Psychedelics (18)
Radiopharmaceuticals (254)
Rare diseases (317)
Real estate (2136)
Recruiting (32)
Regulatory (12666)
Reports (20)
Research institute (1666)
Resumes & cover letters (177)
Rett syndrome (3)
RNA editing (6)
RSV (29)
Schizophrenia (63)
Series A (108)
Series B (77)
Service/supplier (3)
Sickle cell disease (37)
Special edition (10)
Spinal muscular atrophy (61)
Sponsored (23)
Startups (1723)
State (1)
Stomach cancer (17)
Supply chain (36)
Tariffs (38)
The Weekly (35)
Vaccines (426)
Venture capital (23)
Weight loss (124)
Women's health (32)
Worklife (5)
Date
Today (69)
Last 7 days (380)
Last 30 days (1536)
Last 365 days (17416)
2025 (14262)
2024 (19935)
2023 (22477)
2022 (28486)
2021 (29833)
2020 (28299)
2019 (24929)
2018 (18517)
2017 (16567)
2016 (15316)
2015 (17721)
2014 (12886)
2013 (10439)
2012 (10967)
2011 (11298)
2010 (10344)
Location
Africa (368)
Alabama (22)
Alaska (5)
Arizona (104)
Arkansas (6)
Asia (21820)
Australia (3985)
California (4855)
Canada (1606)
China (626)
Colorado (189)
Connecticut (217)
Delaware (171)
Europe (49463)
Florida (747)
Georgia (125)
Idaho (24)
Illinois (418)
India (35)
Indiana (251)
Iowa (11)
Japan (197)
Kansas (72)
Kentucky (29)
Louisiana (9)
Maine (18)
Maryland (606)
Massachusetts (3455)
Michigan (83)
Minnesota (215)
Mississippi (3)
Missouri (57)
Montana (21)
Nebraska (7)
Nevada (43)
New Hampshire (43)
New Jersey (1705)
New Mexico (13)
New York (1566)
North Carolina (617)
North Dakota (2)
Northern California (2400)
Ohio (116)
Oklahoma (3)
Oregon (18)
Pennsylvania (998)
Puerto Rico (11)
Rhode Island (18)
South America (547)
South Carolina (7)
South Dakota (1)
Southern California (1833)
Tennessee (95)
Texas (978)
United States (18115)
Utah (117)
Virginia (101)
Washington D.C. (39)
Washington State (496)
West Virginia (3)
Wisconsin (59)
Wyoming (1)
340,318 Results for "pancreatic cancer action network".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Genialis and Pancreatic Cancer Action Network (PanCAN) Partner to Progress KRAS Diagnostics
Genialis, the RNA-biomarker company, announced a new partnership with the Pancreatic Cancer Action Network to expand the validation of the Genialis™ krasID biomarker in the pancreatic cancer histology.
May 31, 2024
·
4 min read
Biotech Beach
The Pancreatic Cancer Action Network Names Anna Berkenblit, MMSc, MMSc as First-ever Chief Scientific and Medical Officer
The Pancreatic Cancer Action Network, the leading nonprofit in the fight against pancreatic cancer, announces Anna Berkenblit, MD, MMSc, a clinical oncologist and drug developer, as its first-ever chief scientific and medical officer.
April 2, 2024
·
3 min read
Drug Development
FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer
FibroGen, Inc. (NASDAQ: FGEN) announced graduation and completion of the pamrevlumab experimental arm in the Pancreatic Cancer Action Network’s (PanCAN) Precision PromiseSM Phase 2/3 adaptive platform trial, which evaluates pamrevlumab in combination with the chemotherapy treatments gemcitabine and nab-paclitaxel for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
January 25, 2024
·
6 min read
Press Releases
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
October 24, 2025
·
8 min read
Pharm Country
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) is partnering with the Esophageal Cancer Action Network (ECAN) to highlight Esophageal Cancer Awareness Month.
April 29, 2024
·
3 min read
Press Releases
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
September 30, 2025
·
4 min read
Press Releases
Oral Microbes Linked to Increased Risk of Pancreatic Cancer
September 19, 2025
·
5 min read
Press Releases
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
October 15, 2025
·
6 min read
Press Releases
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep’s Tumor-Fighting Mechanism of Action
April 24, 2025
·
6 min read
Press Releases
The FDA Granted Orphan Drug Designation to Biostar Pharma’s Utidelone for the Treatment of Pancreatic Cancer
September 26, 2025
·
4 min read
1 of 34,032
Next
